Literature DB >> 9647732

STAT3 forms stable homodimers in the presence of divalent cations prior to activation.

U Novak1, H Ji, V Kanagasundaram, R Simpson, L Paradiso.   

Abstract

We present evidence that the transcription factor STAT3, derived from uninduced cells, can form stable homodimers, which are independent of the tyrosine phosphorylation status of the protein. The strong interaction, which is resistant to many denaturing agents, is dependent on the presence of divalent cations. The presence of the homodimer was initially observed in immunoprecipitates of STAT3 and was detected upon fractionation of cell lysates. These dimers are different in structure from dimers observed after cytokine stimulation of cells, which results in tyrosine phosphorylation of STAT3 and dimerization involving the SH2 domain of STAT3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647732     DOI: 10.1006/bbrc.1998.8829

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Cytoplasmic STAT proteins associate prior to activation.

Authors:  S Haan; M Kortylewski; I Behrmann; W Müller-Esterl; P C Heinrich; F Schaper
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.

Authors:  A Deb; M Zamanian-Daryoush; Z Xu; S Kadereit; B R Williams
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila.

Authors:  Laura A Ekas; Timothy J Cardozo; Maria Sol Flaherty; Elizabeth A McMillan; Foster C Gonsalves; Erika A Bach
Journal:  Dev Biol       Date:  2010-05-23       Impact factor: 3.582

4.  Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain.

Authors:  Claudia Mertens; Minghao Zhong; Ravi Krishnaraj; Wenxin Zou; Xiaomin Chen; James E Darnell
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

5.  Crystallization and X-ray crystallographic analysis of human STAT1.

Authors:  Xiang Mao; Xiaomin Chen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-15

6.  Structural characterization of unphosphorylated STAT5a oligomerization equilibrium in solution by small-angle X-ray scattering.

Authors:  Pau Bernadó; Yolanda Pérez; Jascha Blobel; Juan Fernández-Recio; Dmitri I Svergun; Miquel Pons
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

7.  Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Authors:  Tiancen Hu; Jennifer E Yeh; Luca Pinello; Jaison Jacob; Srinivas Chakravarthy; Guo-Cheng Yuan; Rajiv Chopra; David A Frank
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

8.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

Authors:  Antje K Kretzschmar; Michaela C Dinger; Christian Henze; Katja Brocke-Heidrich; Friedemann Horn
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

9.  Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle.

Authors:  Minghao Zhong; Melissa A Henriksen; Kenji Takeuchi; Olaf Schaefer; Bin Liu; Johanna ten Hoeve; Zhiyong Ren; Xiang Mao; Xiaomin Chen; Ke Shuai; James E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.

Authors:  Haiyan R Qin; Han-Jong Kim; Joon-Young Kim; Elaine M Hurt; George J Klarmann; Brian T Kawasaki; Maria A Duhagon Serrat; William L Farrar
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.